Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316641 | SCV000666774 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-01-04 | criteria provided, single submitter | clinical testing | The p.S942T variant (also known as c.2825G>C), located in coding exon 21 of the NF1 gene, results from a G to C substitution at nucleotide position 2825. The serine at codon 942 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000695693 | SCV000824208 | likely benign | Neurofibromatosis, type 1 | 2024-11-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000695693 | SCV002562098 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003465205 | SCV004190700 | uncertain significance | Juvenile myelomonocytic leukemia | 2024-02-05 | criteria provided, single submitter | clinical testing |